GILL SIMBA
SEC insider (Form 3/4/5 filer). CIK 0001180763. Director at Foghorn Therapeutics Inc. (FHTX) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 24, 2026. Located in WATERTOWN, MA.
Companies GILL SIMBA has filed insider reports for
- Foghorn Therapeutics Inc. (FHTX): Director
- Serina Therapeutics, Inc. (SER): Director
GILL SIMBA
CIK: 0001180763
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 24, 2026FHTX
Foghorn Therapeutics Inc.
AwardDirectStock Options (Right to buy)
28K shares at avg. $4.08- - Feb 3, 2026SER
Serina Therapeutics, Inc.
AwardDirectStock Option (right to buy)
92K shares- - Jun 17, 2025FHTX
Foghorn Therapeutics Inc.
AwardDirectStock Option (right to buy)
25K shares at avg. $4.79-
1-3 of 3 transactions